Cloud-led Future · Intelligence-driven Hotline +86 21 6228 0217 中文 | EN

16 insurers approved to raise 38.2 billion yuan YTD; perpetual bonds favoured

Overview

Year-to-date, 16 insurers have received approval to raise a combined 38.2 billion yuan of capital, with 24.7 billion yuan already issued—perpetual (capital-supplement) bonds accounting for 68.5% of issuance. The concentration in perpetual instruments reflects carriers’ preference for tier-1-equivalent capital that absorbs losses and counts toward solvency without diluting shareholders or triggering fixed repayment obligations.

Background & Interpretation

1. Regulatory & Industry Context

Insurer capital instruments in China span subordinated debt, capital-supplement bonds, and perpetual bonds, governed by rules from the financial regulator and the PBOC. Perpetual bonds—with no maturity, deferrable coupons, and loss-absorption features—qualify as core or supplementary capital under C-ROSS, helping meet the minimum solvency and comprehensive solvency ratios. The 2024–2025 rule refinements clarified issuance, accounting, and coupon-deferral tax treatment, boosting supply.

2. Core Drivers & Underlying Mechanisms

Drivers include (i) the end of the solvency transition period raising required capital quality; (ii) asset-side mark-to-market and real-estate/equity exposure weighing on ratios; and (iii) a low-rate environment making coupon costs on perpetuals attractive versus equity issuance. The mechanism: perpetuals shore up the solvency ratio quickly, restoring distribution and reinsurance capacity, while deferrable coupons preserve cash in stress. A second-order effect is a lengthening, more resilient capital stack—but also rising fixed-cost leverage that demands disciplined deployment of the proceeds.

3. Market Structure & Operator Impact

Larger carriers with investment-grade ratings access perpetual markets cheaply; smaller or weaker-rated firms face higher coupons or must rely on shareholder capital. The issuer base skews to life insurers with long liabilities needing capital relief. Investors—banks, insurers, and wealth products—weigh loss-absorption and call features, so issuance pricing signals market confidence in an issuer’s credit.

Implications & Outlook

Capital replenishment is likely to remain active as the sector funds growth and meets regime requirements. Watch coupon-deferral risk and call behaviour at first call dates, which will reveal true refinancing conditions.

Takeaways for Industry Participants

  • Carriers: plan capital structure early; balance perpetuals with equity for resilience.
  • Investors: analyse loss-absorption, call, and deferral terms, not just yield.
  • ALM: deploy proceeds to match long liabilities; avoid yield-chasing.
  • Compliance: meet disclosure and solvency-reporting obligations precisely.

This column compiles industry information and shares technical perspectives; it does not constitute investment advice.